SCHEMBL17123095

SCHEMBL17123095

c1ccc(-n2c3ccccc3c3cc(-n4c5ccccc5c5c6ccccc6c6c(c7ccccc7n6-c6ccccc6)c54)ccc32)cc1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 2/20 0.53
KDM4E B2RXH2 1/20 0.53
ATM Q13315 1/20 0.53
KDR P35968 1/20 0.35
KMT2A Q03164 3/20 0.34
MEN1 O00255 2/20 0.34
ALDH1A1 P00352 2/20 0.34
JAK2 O60674 1/20 0.34
JAK3 P52333 1/20 0.34
POLB P06746 1/20 0.34
TSHR P16473 1/20 0.34
BRCA1 P38398 1/20 0.34
HSD17B10 Q99714 1/20 0.34
PTPN1 P18031 2/20 0.33
MAPK8 P45983 2/20 0.33
HDAC4 P56524 1/20 0.33
IL1R1 P14778 1/20 0.33
SIGMAR1 Q99720 1/20 0.32
MAPK9 P45984 1/20 0.32
MAPT P10636 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17245553 1.00 L3MBTL1 (0.53) L3MBTL1KDM4EATMKDRKMT2A
SCHEMBL2627594 0.94 L3MBTL1 (0.56) L3MBTL1KDM4EATMKDRKMT2A
SCHEMBL17123091 0.93 L3MBTL1 (0.46) L3MBTL1KDM4EATMKDRKMT2A
SCHEMBL17245547 0.92 L3MBTL1 (0.58) L3MBTL1KDM4EATMKDRKMT2A
SCHEMBL17123106 0.92 L3MBTL1 (0.58) L3MBTL1KDM4EATMKDRKMT2A
SCHEMBL17228902 0.92 L3MBTL1 (0.62) L3MBTL1KDM4EATMKDRKMT2A
SCHEMBL17990317 0.91 L3MBTL1 (0.53) L3MBTL1KDM4EATMKDRKMT2A
SCHEMBL21105696 0.91 L3MBTL1 (0.53) L3MBTL1KDM4EATMKDRKMT2A
SCHEMBL17228905 0.91 L3MBTL1 (0.56) L3MBTL1KDM4EATMKDRKMT2A
SCHEMBL17123092 0.90 L3MBTL1 (0.49) L3MBTL1KDM4EATMKDRKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20200358005-A1 MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES MERCK PATENT GMBH (DE) 2020-11-12 US disclosed
US-9825239-B2 Benzindolocarbazole derivative, light-emitting element material produced using same, and light-emitting element TORAY INDUSTRIES, INC. (JP) 2017-11-21 US disclosed
US-9825239-B2 Benzindolocarbazole derivative, light-emitting element material produced using same, and light-emitting element TORAY INDUSTRIES, INC. (JP) 2017-11-21 US disclosed
US-20150280140-A1 Benzindolocarbazole Derivative, Light-Emitting Element Material Produced Using Same, and Light-Emitting Element TORAY INDUSTRIES, INC. (JP) 2015-10-01 US disclosed
US-20150280140-A1 Benzindolocarbazole Derivative, Light-Emitting Element Material Produced Using Same, and Light-Emitting Element TORAY INDUSTRIES, INC. (JP) 2015-10-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150280140-A1 Benzindolocarbazole Derivative, Light-Emitting Element Material Produced Using Same, and Light-Emitting Element L3MBTL4, L3MBTL1, IL4I1 L3MBTL1 2/4885KDM4E 523/4885ATM 3818/4885
US-20200358005-A1 MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES PIEZO1, L1CAM, EFNA1 L3MBTL1 2124/4885KDM4E 2430/4885ATM 3991/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.